Sudan Loganathan
Stock Analyst at Stephens & Co.
(0)
# 4894
Out of 5,321 analysts
35
Total ratings
14.81%
Success rate
-29.73%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ELEV Elevation Oncology | Downgrades: Equal-Weight | 5 5 | 0.36 | 1288.89% | 4 | Mar 24, 2025 | |
IMNM Immunome | Reiterates: Overweight | 30 30 | 8.47 | 254.19% | 2 | Mar 20, 2025 | |
CPRX Catalyst Pharmaceuti... | Reiterates: Overweight | 33 33 | 23.31 | 41.57% | 2 | Feb 27, 2025 | |
ADCT ADC Therapeutics | Maintains: Overweight | 6 8 | 1.33 | 501.5% | 2 | Feb 24, 2025 | |
IDYA IDEAYA Biosciences | Reiterates: Overweight | 50 50 | 18.7 | 167.38% | 2 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 29 29 | 37.3 | -22.25% | 4 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 15 15 | 8.52 | 76.06% | 2 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 31 31 | 11.45 | 170.74% | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 60 60 | 32.98 | 81.93% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 140 140 | 86.4 | 62.04% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.36 | 267.65% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 4 | 1.54 | 159.74% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 9.16 | 500.44% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 1.08 | 1103.7% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 25 25 | 12.13 | 106.1% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 0.37 | 1251.35% | 2 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | 1.92 | 941.67% | 1 | May 14, 2024 |